Global Neurostimulation Market Revenue Forecast 2023

Q: Which Country is Predicted to Witness Significant Growth?

India is predicted to witness significant growth. Read Report

Neurostimulation Market Outlook for 2023 to 2033

The global Neurostimulation Market valuation is US$ 6,221.2 million in 2023. The neurostimulation market is expected to grow at a promising CAGR of 9.5% through 2033, with a forecast valuation of US$ 15,417.4 million by 2033.

Attribute	Details
Neurostimulation Market Size, 2022	US$ 5,584.5 million
Neurostimulation Market Size, 2023	US$ 6,221.2 million
Neurostimulation Market Size, 2033	US$ 15,417.4 million
Value CAGR (2023 to 2033)	9.5%

Key Trends Impacting Sales of Neurostimulation Devices

Key players are developing neurostimulation devices that can be prescribed by health professionals for remote use. Portable neurostimulation devices for Parkinson's, back pain, etc., have been introduced for faster patient outcomes.
Increasing research and development efforts in neurostimulation to arrive at new applications and treat disorders like autism, stroke, sleep disorders, obesity, and several others are predicted to elevate the scope of neurostimulation.
Rising demand for technologies that offer better outcomes, optimized inter-device communication, neurological episode on-set, and better user interface.
Soaring levels of the geriatric population, with higher risks of neurological disorders like epilepsy, essential tremors, Parkinson’s disease, and depression-related disorders, are predicted to boost the demand for neurostimulation.
Increasing acceptance of neurostimulation systems and devices to treat chronic pain, particularly in emerging economies like China, India, Brazil, etc.
The rise in the clearance from the FDA for innovative neurostimulators with new applications is enhancing the market scope for neurostimulation.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Growth of the Neurostimulation Market Vs. Forecast Outlook

Attributes	Details
Neurostimulation Market Size (2018)	US$ 3396.59 million
Neurostimulation Market Size (2022)	US$ 5,584.5 million
Neurostimulation Market CAGR (2018 to 2022)	11.4%

The neurostimulation market was valued at US$ 5,584.5 million in 2022, expanding at a CAGR of 11.4% from 2018 to 2022. From 2023 onwards, the growth rate for neurostimulation is predicted to reduce slightly, exhibiting a CAGR of 9.5% through 2033.

The following factors are pushing the market growth.

Rising demand for MRI-safe neurostimulation systems to effectively treat several diseases linked with neurotic disorders.
Increasing utilization of neurostimulation to treat various debilitating health conditions like Parkinson’s disease, incontinence, depression, gastroparesis, and essential tremors. Healthcare professionals are directing patients without relief from surgical therapies and medications toward neurostimulation as a potential treatment option.
By opting for neurostimulation, patients who are extremely paralyzed or enduring intense loss of different sense organs can feel betterment in their quality of life. Thus, neurostimulation is extremely instrumental in hearing aids, artificial limbs, artificial vision, and other prosthetics.

Category-wise Insights

Spinal Cord Stimulator (SCS) Accounts for a Leading Market Share

Top Product	Spinal Cord Stimulator
Market Share (2023)	52.3%

The spinal cord stimulator segment accounts for 52.3% of the market share in 2023. Demand for spinal cord stimulators is rising on account of increasing awareness about the benefits of using this product. The application of spinal cord stimulators is predicted to escalate over the forecast period due to:

Increasing geriatric population
Rising levels of obesity
Surging demand for an alternative to opioids for treatment of diseases
Expanding clinical evidence that supports the efficacy of spinal cord stimulator

Substantial Deployment of Neurostimulation for Pain Management

Top Application	Pain Management
Market Share (2023)	45.3%

Neurostimulation in pain management is gaining high traction for treating multiple chronic pain conditions, such as neck pain, migraines, neuropathic pain, arthritis pain, etc. Demand for neurostimulation to control pain is rising due to its effectiveness, which curtails pain by up to 50% and enhances patient’s quality of life. Apart from this, the results obtained from neurostimulation treatment can last a long time, thus fueling its application in pain management.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Insights

Countries	CAGR (2023 to 2033)
India	14.3%
United Kingdom	5.7%
China	12.4%
Australia	10.5%

High Profitable Prospects for Neurostimulation Devices in India

As per the study, India is predicted to witness a robust growth rate of 14.3% CAGR through 2033. The following factors are contributing to the sales of neurostimulation devices in the country:

Increasing adoption of advanced technologies to produce neurostimulators like responsive neurostimulation and magnetic neurostimulation that offer more efficiency, propelling sales of neurostimulation to treat various ailments.
Increasing cognizance and acceptance of neurostimulation in India as an alternate treatment for neurological disorders and chronic pain.

Research Breakthroughs in the United Kingdom to Propel Neurostimulation Market

The United Kingdom market is predicted to expand at a 5.7% CAGR over the forecast period. The country houses key players offering cutting-edge neurostimulation devices and enjoys early access to these latest innovations by healthcare professionals, indicating an already established market for neurostimulation. Therefore, the United Kingdom market is predicted to witness modest sales over the forecast period.

The following factors are predicted to fuel market growth through 2033:

Constant developments of novel devices and technological upgrades by market participants and research affiliates, thus improving therapeutic outcomes and gaining a competitive edge in the market.
Key players are also targeting new markets for their innovations to boost their contribution to the global forum.

Remunerative Prospects in China Attracting Neurostimulation Key Providers

China is another lucrative market for neurostimulation devices in the Asia Pacific region, besides India. Given below are the leading factors that are supplementing market growth:

Ever-increasing population in China, particularly those suffering from health conditions, is creating a huge market for neurostimulation. Growth prospects are especially high for spinal cord stimulation (SCS) and deep brain stimulation (DBS) in China.
Growing awareness about neurostimulation as a viable treatment option for chronic pain and neurological disorders.

Investors Eyeing Australia as a Profitable Market for Neurostimulation Devices

Australia is predicted to expand at an impressive CAGR of 10.5% through 2033. Due to significant business opportunities in Australia, key players are investing in the country. Given below are the key factors that are spurring sales of neurostimulation:

Constantly rising geriatric population, which has a higher chance of developing neurological disorders like Alzheimer's disease, Parkinson's disease, and stroke.
Increasing support from the Australian government to develop and use neurostimulation devices via the Medical Research Future Fund (MRFF).

Market Outlook for Neurostimulation in Japan

The neurostimulation market in Japan is expanding at a healthy pace. This can be attributed to the following factors:

Japan has a rapidly rising aging population. Elderly people are susceptible to neurological disorders, which can be treated with the help of neurostimulation devices.
The government in Japan is highly committed to providing high-quality healthcare and the latest medical technology, which is predicted to be beneficial for the growth of the neurostimulation market.

Neurostimulation devices are finding high utilization by healthcare professionals in Japan for an effective pain management treatment.

Competitive Landscape in the Neurostimulation Market

Key players in the neurostimulation market are focusing on product development, which caters to more applications meanwhile enhancing these devices' efficiency, effectiveness, and user-friendliness. Apart from this, companies are leading clinical trials to test the efficacy and safety of their devices, boosting customer confidence and obtaining regulatory approvals for their neurostimulation devices.

Market participants are significantly investing in the sales and marketing of their product portfolio to healthcare professionals. This includes developing educational materials and exhibiting at trade shows for businesses. Additionally, companies are forming alliances with other players to extend their market reach as well as product portfolio.

Key Developments Observed in the Neurostimulation Market

In September 2023, a collaborative study including the universities of Surrey and Oxford, Radboud University, and Loughborough University was conducted to explore the scope of neurostimulation to boost mathematical learning. For this, high-frequency transcranial random noise stimulation was applied to stimulate certain brain regions and enhance the mathematical capabilities of participants. The research suggests a positive impact of brain stimulation on mathematical skills.
In April 2023, Neuspera Medical obtained FDA approval for a micro-implant neurostimulation therapy system. The system deploys a wearable device and a wireless platform for peripheral nerve stimulation.
In December 2022, the American Association for the Advancement of Science announced the development of new neurostimulation technology for advancements in the research and treatment of Parkinson’s disease. Latest innovations in DBS stimulators have opened doors to research the results of the recent DBS advances on Parkinson’s disease.

Key Players in the Neurostimulation Market

Boston Scientific Corporation
Cyberonics Inc.
St. Jude Medical Inc.
Medtronic Inc.
NeuroPace Inc.
NeuroSigma, Inc.
Others

Key Segments

By Type:

Spinal Cord Stimulators
Deep Brain Stimulators
Sacral Nerve Stimulators
Vagus Nerve Stimulators
Others

By Application:

Pain Management
Hearing Loss
Urinary Incontinence
Parkinson's disease
Epilepsy
Others

By Region:

North America
Latin America
Asia Pacific
Japan
Western Europe
Eastern Europe
Middle East & Africa

Frequently Asked Questions

How Big is the Neurostimulation Market?

The neurostimulation market is worth US$ 6,221.2 million in 2023.

What is the Growth Potential of the Neurostimulation Market?

The market is expected to expand at a CAGR of 9.5% through 2033.

What is the Future of the Neurostimulation Market?

The neurostimulation market is anticipated to account for US$ 15,417.4 million by 2033.

Which Country is Predicted to Witness Significant Growth?

India is predicted to witness significant growth.

Which Application Contributes Considerably to the Neurostimulation Market?

Pain management makes a significant contribution to the growth of the neurostimulation market.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Product Life Cycle Analysis

3.5. Supply Chain Analysis

3.5.1. Supply Side Participants and their Roles

3.5.1.1. Producers

3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

3.5.1.3. Wholesalers and Distributors

3.5.2. Value Added and Value Created at Node in the Supply Chain

3.5.3. List of Raw Material Suppliers

3.5.4. List of Existing and Potential Buyer’s

3.6. Investment Feasibility Matrix

3.7. Value Chain Analysis

3.7.1. Profit Margin Analysis

3.7.2. Wholesalers and Distributors

3.7.3. Retailers

3.8. PESTLE and Porter’s Analysis

3.9. Regulatory Landscape

3.9.1. By Key Regions

3.9.2. By Key Countries

3.10. Regional Parent Market Outlook

3.11. Production and Consumption Statistics

3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Type, 2018 to 2022

5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Type, 2023 to 2033

5.3.1. Spinal Cord Stimulators

5.3.2. Deep Brain Stimulators

5.3.3. Sacral Nerve Stimulators

5.3.4. Vagus Nerve Stimulators

5.3.5. Others

5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022

5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022

6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033

6.3.1. Pain Management

6.3.2. Hearing Loss

6.3.3. Urinary Incontinence

6.3.4. Parkinson's disease

6.3.5. Epilepsy

6.3.6. Others

6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

7.1. Introduction

7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

7.3.1. North America

7.3.2. Latin America

7.3.3. Western Europe

7.3.4. Eastern Europe

7.3.5. South Asia and Pacific

7.3.6. East Asia

7.3.7. Middle East and Africa

7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

8.2.1. By Country

8.2.1.1.USA

8.2.1.2. Canada

8.2.2. By Type

8.2.3. By Application

8.3. Market Attractiveness Analysis

8.3.1. By Country

8.3.2. By Type

8.3.3. By Application

8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

9.2.1. By Country

9.2.1.1. Brazil

9.2.1.2. Mexico

9.2.1.3. Rest of Latin America

9.2.2. By Type

9.2.3. By Application

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Type

9.3.3. By Application

9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

10.2.1. By Country

10.2.1.1. Germany

10.2.1.2. UK

10.2.1.3. France

10.2.1.4. Spain

10.2.1.5. Italy

10.2.1.6. Rest of Western Europe

10.2.2. By Type

10.2.3. By Application

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Type

10.3.3. By Application

10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

11.2.1. By Country

11.2.1.1. Poland

11.2.1.2. Russia

11.2.1.3. Czech Republic

11.2.1.4. Romania

11.2.1.5. Rest of Eastern Europe

11.2.2. By Type

11.2.3. By Application

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Type

11.3.3. By Application

11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

12.2.1. By Country

12.2.1.1. India

12.2.1.2. Bangladesh

12.2.1.3. Australia

12.2.1.4. New Zealand

12.2.1.5. Rest of South Asia and Pacific

12.2.2. By Type

12.2.3. By Application

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Type

12.3.3. By Application

12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

13.2.1. By Country

13.2.1.1. China

13.2.1.2. Japan

13.2.1.3. South Korea

13.2.2. By Type

13.2.3. By Application

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Type

13.3.3. By Application

13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

14.2.1. By Country

14.2.1.1. GCC Countries

14.2.1.2. South Africa

14.2.1.3. Israel

14.2.1.4. Rest of MEA

14.2.2. By Type

14.2.3. By Application

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Type

14.3.3. By Application

14.4. Key Takeaways

15. Key Countries Market Analysis

15.1. USA

15.1.1. Pricing Analysis

15.1.2. Market Share Analysis, 2022

15.1.2.1. By Type

15.1.2.2. By Application

15.2. Canada

15.2.1. Pricing Analysis

15.2.2. Market Share Analysis, 2022

15.2.2.1. By Type

15.2.2.2. By Application

15.3. Brazil

15.3.1. Pricing Analysis

15.3.2. Market Share Analysis, 2022

15.3.2.1. By Type

15.3.2.2. By Application

15.4. Mexico

15.4.1. Pricing Analysis

15.4.2. Market Share Analysis, 2022

15.4.2.1. By Type

15.4.2.2. By Application

15.5. Germany

15.5.1. Pricing Analysis

15.5.2. Market Share Analysis, 2022

15.5.2.1. By Type

15.5.2.2. By Application

15.6. UK

15.6.1. Pricing Analysis

15.6.2. Market Share Analysis, 2022

15.6.2.1. By Type

15.6.2.2. By Application

15.7. France

15.7.1. Pricing Analysis

15.7.2. Market Share Analysis, 2022

15.7.2.1. By Type

15.7.2.2. By Application

15.8. Spain

15.8.1. Pricing Analysis

15.8.2. Market Share Analysis, 2022

15.8.2.1. By Type

15.8.2.2. By Application

15.9. Italy

15.9.1. Pricing Analysis

15.9.2. Market Share Analysis, 2022

15.9.2.1. By Type

15.9.2.2. By Application

15.10. Poland

15.10.1. Pricing Analysis

15.10.2. Market Share Analysis, 2022

15.10.2.1. By Type

15.10.2.2. By Application

15.11. Russia

15.11.1. Pricing Analysis

15.11.2. Market Share Analysis, 2022

15.11.2.1. By Type

15.11.2.2. By Application

15.12. Czech Republic

15.12.1. Pricing Analysis

15.12.2. Market Share Analysis, 2022

15.12.2.1. By Type

15.12.2.2. By Application

15.13. Romania

15.13.1. Pricing Analysis

15.13.2. Market Share Analysis, 2022

15.13.2.1. By Type

15.13.2.2. By Application

15.14. India

15.14.1. Pricing Analysis

15.14.2. Market Share Analysis, 2022

15.14.2.1. By Type

15.14.2.2. By Application

15.15. Bangladesh

15.15.1. Pricing Analysis

15.15.2. Market Share Analysis, 2022

15.15.2.1. By Type

15.15.2.2. By Application

15.16. Australia

15.16.1. Pricing Analysis

15.16.2. Market Share Analysis, 2022

15.16.2.1. By Type

15.16.2.2. By Application

15.17. New Zealand

15.17.1. Pricing Analysis

15.17.2. Market Share Analysis, 2022

15.17.2.1. By Type

15.17.2.2. By Application

15.18. China

15.18.1. Pricing Analysis

15.18.2. Market Share Analysis, 2022

15.18.2.1. By Type

15.18.2.2. By Application

15.19. Japan

15.19.1. Pricing Analysis

15.19.2. Market Share Analysis, 2022

15.19.2.1. By Type

15.19.2.2. By Application

15.20. South Korea

15.20.1. Pricing Analysis

15.20.2. Market Share Analysis, 2022

15.20.2.1. By Type

15.20.2.2. By Application

15.21. GCC Countries

15.21.1. Pricing Analysis

15.21.2. Market Share Analysis, 2022

15.21.2.1. By Type

15.21.2.2. By Application

15.22. South Africa

15.22.1. Pricing Analysis

15.22.2. Market Share Analysis, 2022

15.22.2.1. By Type

15.22.2.2. By Application

15.23. Israel

15.23.1. Pricing Analysis

15.23.2. Market Share Analysis, 2022

15.23.2.1. By Type

15.23.2.2. By Application

16. Market Structure Analysis

16.1. Competition Dashboard

16.2. Competition Benchmarking

16.3. Market Share Analysis of Top Players

16.3.1. By Regional

16.3.2. By Type

16.3.3. By Application

17. Competition Analysis

17.1. Competition Deep Dive

17.1.1. Boston Scientific Corporation

17.1.1.1. Overview

17.1.1.2. Product Portfolio

17.1.1.3. Profitability by Market Segments

17.1.1.4. Sales Footprint

17.1.1.5. Strategy Overview

17.1.1.5.1. Marketing Strategy

17.1.1.5.2. Product Strategy

17.1.1.5.3. Channel Strategy

17.1.2. Cyberonics Inc.

17.1.2.1. Overview

17.1.2.2. Product Portfolio

17.1.2.3. Profitability by Market Segments

17.1.2.4. Sales Footprint

17.1.2.5. Strategy Overview

17.1.2.5.1. Marketing Strategy

17.1.2.5.2. Product Strategy

17.1.2.5.3. Channel Strategy

17.1.3. St. Jude Medical Inc.

17.1.3.1. Overview

17.1.3.2. Product Portfolio

17.1.3.3. Profitability by Market Segments

17.1.3.4. Sales Footprint

17.1.3.5. Strategy Overview

17.1.3.5.1. Marketing Strategy

17.1.3.5.2. Product Strategy

17.1.3.5.3. Channel Strategy

17.1.4. Medtronic Inc.

17.1.4.1. Overview

17.1.4.2. Product Portfolio

17.1.4.3. Profitability by Market Segments

17.1.4.4. Sales Footprint

17.1.4.5. Strategy Overview

17.1.4.5.1. Marketing Strategy

17.1.4.5.2. Product Strategy

17.1.4.5.3. Channel Strategy

17.1.5. NeuroPace Inc.

17.1.5.1. Overview

17.1.5.2. Product Portfolio

17.1.5.3. Profitability by Market Segments

17.1.5.4. Sales Footprint

17.1.5.5. Strategy Overview

17.1.5.5.1. Marketing Strategy

17.1.5.5.2. Product Strategy

17.1.5.5.3. Channel Strategy

17.1.6. NeuroSigma, Inc.

17.1.6.1. Overview

17.1.6.2. Product Portfolio

17.1.6.3. Profitability by Market Segments

17.1.6.4. Sales Footprint

17.1.6.5. Strategy Overview

17.1.6.5.1. Marketing Strategy

17.1.6.5.2. Product Strategy

17.1.6.5.3. Channel Strategy

17.1.7. MED-EL GmbH

17.1.7.1. Overview

17.1.7.2. Product Portfolio

17.1.7.3. Profitability by Market Segments

17.1.7.4. Sales Footprint

17.1.7.5. Strategy Overview

17.1.7.5.1. Marketing Strategy

17.1.7.5.2. Product Strategy

17.1.7.5.3. Channel Strategy

17.1.8. Synapse Biomedical Inc.

17.1.8.1. Overview

17.1.8.2. Product Portfolio

17.1.8.3. Profitability by Market Segments

17.1.8.4. Sales Footprint

17.1.8.5. Strategy Overview

17.1.8.5.1. Marketing Strategy

17.1.8.5.2. Product Strategy

17.1.8.5.3. Channel Strategy

17.1.9. NDI Medical LLC

17.1.9.1. Overview

17.1.9.2. Product Portfolio

17.1.9.3. Profitability by Market Segments

17.1.9.4. Sales Footprint

17.1.9.5. Strategy Overview

17.1.9.5.1. Marketing Strategy

17.1.9.5.2. Product Strategy

17.1.9.5.3. Channel Strategy

17.1.10. EnteroMedics Inc.

17.1.10.1. Overview

17.1.10.2. Product Portfolio

17.1.10.3. Profitability by Market Segments

17.1.10.4. Sales Footprint

17.1.10.5. Strategy Overview

17.1.10.5.1. Marketing Strategy

17.1.10.5.2. Product Strategy

17.1.10.5.3. Channel Strategy

17.1.11. ImThera Medical

17.1.11.1. Overview

17.1.11.2. Product Portfolio

17.1.11.3. Profitability by Market Segments

17.1.11.4. Sales Footprint

17.1.11.5. Strategy Overview

17.1.11.5.1. Marketing Strategy

17.1.11.5.2. Product Strategy

17.1.11.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Neurostimulation Market

Neurostimulation Market Analysis by Spinal Cord Stimulators, Vagus Nerve Stimulators, and Deep Brain Stimulator Types for 2023 to 2033